DinaSParekhMD

Physician

Dr. Parekh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 2008 - 2011
San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 2001 - 2004
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2001
Georgetown UniversityBS, Biology/English double major, Cum Laude, 1993 - 1997

PubMed

2 citations
Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
Dina S Parekh, William A Eaton, Swee Lay Thein
Blood. 2024-03-07
1 citations
The Sickle Cell Pain Action Plan: A low health literacy, pictographic tool to enhance self-management, and guideline concordance.
Patrick T Reeves, Philip L Rogers, Sean J Hipp, Richard C Zanetti, Sofia Echelmeyer
Pediatric Blood & Cancer. 2022-12-01
2 citations
Affirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event.
Scott W Penney, Jenny H Jung, Aaron J Ballantyne, Dina S Parekh, David A Klein
Journal of Pediatric Hematology/oncology. 2022-07-01

Abstracts/Posters

A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients with Suboptimal Metabolites Successfully Corrected with Allopurinol
Dina S. Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019